QA: Matinas BioPharma Holdings Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001582554_2023_Matinas_BioPharma_Holdings_Inc.pdf

Logs

Graph

Absolute values for 0001582554, Matinas BioPharma Holdings Inc.

  xvar xval
0 AssetsCurrent 34,532,000
1 IntangibleAssetsNetIncludingGoodwill 4,353,000
2 PropertyPlantAndEquipmentNet 2,091,000
3 remainder_Assets 3,843,000
4 LiabilitiesCurrent 4,286,000
5 LiabilitiesNoncurrent 3,896,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 11,100,000
9 ResearchAndDevelopmentExpense 16,678,000
10 remainder_Expenses 0
11 remainder_Revenues 3,188,000
12 remainder_NetIncome 3,593,000
13 remainder_ComprehensiveNetIncome -679,000
  yvar yval
0 Assets 44,819,000
1 Liabilities 8,182,000
2 Expenses 27,778,000
3 Revenues 3,188,000
4 StockholdersEquity 36,637,000
5 NetIncome -20,997,000
6 ComprehensiveNetIncome -21,336,500
7 BaseVar 44,119,500
8 EconomicCapitalRatio 1.57

Edgar->Model Mapping

Feature Distribution

Change over Time